Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Assets (2021 - 2025)

Lucid Diagnostics' Assets history spans 5 years, with the latest figure at $40.4 million for Q4 2025.

  • For Q4 2025, Assets rose 31.68% year-over-year to $40.4 million; the TTM value through Dec 2025 reached $40.4 million, up 31.68%, while the annual FY2025 figure was $40.4 million, 31.68% up from the prior year.
  • Assets reached $40.4 million in Q4 2025 per LUCD's latest filing, down from $53.2 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $62.1 million in Q1 2022 to a low of $3.3 million in Q3 2021.
  • Average Assets over 5 years is $37.6 million, with a median of $36.2 million recorded in 2022.
  • The largest YoY upside for Assets was 1064.21% in 2022 against a maximum downside of 44.9% in 2022.
  • A 5-year view of Assets shows it stood at $59.0 million in 2021, then plummeted by 44.9% to $32.5 million in 2022, then dropped by 16.12% to $27.3 million in 2023, then grew by 12.63% to $30.7 million in 2024, then skyrocketed by 31.68% to $40.4 million in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Assets are $40.4 million (Q4 2025), $53.2 million (Q3 2025), and $38.7 million (Q2 2025).